Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > Feature article about Theralase on biotuesdays.com website

<< Previous

Bullboard Posts

Next >>

Comment by skys1on Jan 03, 2023 1:25pm

275 Views

Post# 35201052

RE:Feature article about Theralase on biotuesdays.com website

If I knew nothing about Theralase, after reading this article on biotuesday.com describing TLT's successes and potential someone told me the stock was selling for .25, I wouldn't believe them.
This article convinces me that my original opinion on what caused all those unusual moves by TLT back in Oct. was my belief that they must have had early "partnering talks" with one or more big pharma members. I am now more convinced than ever that's what happened and become more convinced of it each month. Now they are obviously even willing to mention it publically

<< Previous

Bullboard Posts

Next >>

Rig Count Soars as Utilization Surpasses Industry Averages